These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17606590)

  • 41. Very low lead exposures and children's neurodevelopment.
    Bellinger DC
    Curr Opin Pediatr; 2008 Apr; 20(2):172-7. PubMed ID: 18332714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal and childhood exposure to pesticides and neurobehavioral development: review of epidemiological studies.
    Jurewicz J; Hanke W
    Int J Occup Med Environ Health; 2008; 21(2):121-32. PubMed ID: 18614459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developmental origins of environmentally induced disease and dysfunction International Conference on Foetal Programming and Developmental Toxicity, Tórshavn, Faroe Islands, 20-24 May, 2007.
    Grandjean P; Weihe P
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):71-2. PubMed ID: 18226056
    [No Abstract]   [Full Text] [Related]  

  • 44. Pesticide toxicity and the developing brain.
    Eskenazi B; Rosas LG; Marks AR; Bradman A; Harley K; Holland N; Johnson C; Fenster L; Barr DB
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):228-36. PubMed ID: 18226078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A prospective study of neurodevelopment of uninfected children born to human immunodeficiency virus type 1 positive mothers].
    Gómez C; Archila ME; Rugeles C; Carrizosa J; Rugeles MT; Cornejo JW
    Rev Neurol; 2009 Mar 16-31; 48(6):287-91. PubMed ID: 19291651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The faroes statement: human health effects of developmental exposure to chemicals in our environment.
    Grandjean P; Bellinger D; Bergman A; Cordier S; Davey-Smith G; Eskenazi B; Gee D; Gray K; Hanson M; van den Hazel P; Heindel JJ; Heinzow B; Hertz-Picciotto I; Hu H; Huang TT; Jensen TK; Landrigan PJ; McMillen IC; Murata K; Ritz B; Schoeters G; Skakkebaek NE; Skerfving S; Weihe P
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):73-5. PubMed ID: 18226057
    [No Abstract]   [Full Text] [Related]  

  • 47. Causal inferences regarding prenatal alcohol exposure and childhood externalizing problems.
    D'Onofrio BM; Van Hulle CA; Waldman ID; Rodgers JL; Rathouz PJ; Lahey BB
    Arch Gen Psychiatry; 2007 Nov; 64(11):1296-304. PubMed ID: 17984398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal exposure to neurotoxicants and neurodevelopment in Mexican neonates.
    Rooney JP; Dórea JG
    J Expo Sci Environ Epidemiol; 2012 Jul; 22(4):425-6. PubMed ID: 22713535
    [No Abstract]   [Full Text] [Related]  

  • 49. The management of infantile spasms.
    Desguerre I; Nabbout R; Dulac O
    Arch Dis Child; 2008 Jun; 93(6):462-3. PubMed ID: 18192314
    [No Abstract]   [Full Text] [Related]  

  • 50. Possible teratogenic effects of intrauterine exposure to chlorpyrifos (Dursban).
    Jackson RJ; Erickson JD; McGeehin M; Moore CA; Roberts HE; Lary JM
    Arch Environ Health; 1999; 54(2):141-3. PubMed ID: 10094293
    [No Abstract]   [Full Text] [Related]  

  • 51. Prenatal acetaminophen exposure and neurodevelopment: State of the evidence.
    Talge NM
    Paediatr Perinat Epidemiol; 2020 May; 34(3):227-229. PubMed ID: 32072660
    [No Abstract]   [Full Text] [Related]  

  • 52. Complexity of foetal alcohol or drug neuroimpairments.
    Elgen I; Bruaroy S; Laegreid LM
    Acta Paediatr; 2007 Dec; 96(12):1730-3. PubMed ID: 17971190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder.
    Pringsheim T; Sandor P; Lang A; Shah P; O'Connor P
    J Dev Behav Pediatr; 2009 Apr; 30(2):115-21. PubMed ID: 19322105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene-environment interaction is now hype.
    Lagercrantz H
    Acta Paediatr; 2007 Sep; 96(9):1253. PubMed ID: 17718775
    [No Abstract]   [Full Text] [Related]  

  • 55. Human exposure and risk from indoor use of chlorpyrifos.
    Gibson JE; Peterson RK; Shurdut BA
    Environ Health Perspect; 1998 Jun; 106(6):303-6. PubMed ID: 9618344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Course of child development and hyperactivity].
    Hirasing RA; Kuijper AE; Stolk HJ
    Ned Tijdschr Geneeskd; 1988 Sep; 132(37):1688-92. PubMed ID: 3173558
    [No Abstract]   [Full Text] [Related]  

  • 57. Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.
    Poulton A; Nanan R
    Pediatrics; 2008 Jul; 122(1):221; author reply 221-2. PubMed ID: 18596017
    [No Abstract]   [Full Text] [Related]  

  • 58. [Psychomotor profile of children between 5 and 12 years of age, clinically diagnosed with attention deficit hyperactivity disorder in Colombia].
    Vidarte JA; Ezquerro M; Giráldez MA
    Rev Neurol; 2009 Jul 16-31; 49(2):69-75. PubMed ID: 19598135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal and postnatal mercury exposure, breastfeeding and neurodevelopment during the first 5 years.
    Marques RC; Dórea JG; Bernardi JV; Bastos WR; Malm O
    Cogn Behav Neurol; 2009 Jun; 22(2):134-41. PubMed ID: 19506431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal study of prenatal and postnatal lead exposure and early cognitive development in Al-Kharj, Saudi Arabia: a preliminary results of cord blood lead levels.
    Al-Saleh I; Shinwari N; Nester M; Mashhour A; Moncari L; El Din Mohamed G; Rabah A
    J Trop Pediatr; 2008 Oct; 54(5):300-7. PubMed ID: 18353786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.